All Stories

  1. The Yield and Clinical Impact of Genetic Testing in Older Patients with Dilated Cardiomyopathy
  2. Clinical features and outcomes in carriers of pathogenic desmoplakin variants
  3. A novel tool for arrhythmic risk stratification in desmoplakin gene variant carriers
  4. Arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy
  5. Performance of the PRIMaCY sudden death risk prediction model for childhood hypertrophic cardiomyopathy: implications for implantable cardioverter-defibrillator decision-making
  6. An mTORC1‐Dependent Mouse Model for Cardiac Sarcoidosis
  7. Risks of Ventricular Arrhythmia and Heart Failure in Carriers of RBM20 Variants
  8. 2023 ESC Guidelines for the management of cardiomyopathies
  9. Right ventricular function is a predictor for sustained ventricular tachycardia requiring anti-tachycardic pacing in arrhythmogenic ventricular cardiomyopathy: insight into transvenous vs. subcutaneous implantable cardioverter defibrillator insertion
  10. Circulating c-Met–Expressing Memory T Cells Define Cardiac Autoimmunity
  11. Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator
  12. Correction to: The genetic architecture of Plakophilin 2 cardiomyopathy
  13. The genetic architecture of Plakophilin 2 cardiomyopathy
  14. Evidence-Based Assessment of Genes in Dilated Cardiomyopathy
  15. International Evidence Based Reappraisal of Genes Associated With Arrhythmogenic Right Ventricular Cardiomyopathy Using the Clinical Genome Resource Framework
  16. Myocardial strain analysis in family screening for genetic dilated cardiomyopathy: Testing the boundaries of normality?
  17. An Evidence-based Assessment of Genes in Dilated Cardiomyopathy
  18. The novel desmin variant p.Leu115Ile is associated with a unique form of biventricular Arrhythmogenic Cardiomyopathy
  19. State of the Art Review on Genetics and Precision Medicine in Arrhythmogenic Cardiomyopathy
  20. Influenza-associated cardiac injury: a disease of the cardiac conduction system?
  21. Filamin C variants are associated with a distinctive clinical and immunohistochemical arrhythmogenic cardiomyopathy phenotype
  22. Towards precision disease-modelling in experimental myocarditis
  23. Arrhythmogenic Cardiomyopathy: A Disease or Merely a Phenotype?
  24. Short-term effects of angiotensin receptor-neprilysin inhibitors on diastolic strain and tissue doppler parameters in heart failure patients with reduced ejection fraction: A pilot trial
  25. Dilated cardiomyopathy and arrhythmogenic left ventricular cardiomyopathy: a comprehensive genotype-imaging phenotype study
  26. Definition and treatment of arrhythmogenic cardiomyopathy: an updated expert panel report
  27. Left ventricular non-compaction: have we reached the limits of conventional imaging?
  28. Prevalence of 18F-fluorodeoxyglucose positron emission tomography abnormalities in patients with arrhythmogenic right ventricular cardiomyopathy
  29. Effect of Trimetazidine Dihydrochloride Therapy on Exercise Capacity in Patients With Nonobstructive Hypertrophic Cardiomyopathy
  30. Arrhythmogenic cardiomyopathies (ACs): diagnosis, risk stratification and management
  31. OUP accepted manuscript
  32. Arrhythmogenic right ventricular cardiomyopathy as a hidden cause of paediatric myocarditis presentation
  33. No major role for rare plectin variants in arrhythmogenic right ventricular cardiomyopathy
  34. Genetic basis of arrhythmogenic cardiomyopathy
  35. Characterizing the Molecular Pathology of Arrhythmogenic Cardiomyopathy in Patient Buccal Mucosa Cells
  36. Clinical Significance of Epsilon Waves in Arrhythmogenic Cardiomyopathy
  37. Arrhythmic risk assessment in genotyped families with arrhythmogenic right ventricular cardiomyopathy
  38. Left dominant arrhythmogenic cardiomyopathy: A morbid association of ventricular arrhythmias and unexplained infero-lateral T-wave inversion
  39. Clear cell sarcoma of the jejunum: a case report